{"record":{"leader":"cx  a22     3  45","datafield":[{"ind2":" ","ind1":" ","subfield":[{"code":"a","content":"http://viaf.org/viaf/145160243008852432764"},{"code":2,"content":"VIAF"},{"code":"C","content":"VIAF"},{"code":"d","content":20210804}],"tag":"035"},{"ind2":" ","ind1":" ","subfield":{"code":"a","content":"20200922afrey50      ba0"},"tag":100},{"ind2":" ","ind1":" ","subfield":{"code":"a","content":"fre"},"tag":101},{"ind2":" ","ind1":" ","subfield":{"code":"a","content":"FR"},"tag":102},{"ind2":" ","ind1":" ","subfield":{"code":"a","content":1994},"tag":103},{"ind2":" ","ind1":" ","subfield":[{"code":"a","content":0},{"code":"b","content":1},{"code":"c","content":0}],"tag":106},{"ind2":" ","ind1":" ","subfield":{"code":"a","content":"aa"},"tag":120},{"ind2":" ","ind1":" ","subfield":{"code":"a","content":"AFNOR"},"tag":152},{"ind2":1,"ind1":" ","subfield":[{"code":7,"content":"ba0yba0y"},{"code":9,"content":0},{"code":"a","content":"Burgniard"},{"code":"b","content":"Sarah"},{"code":"f","content":"1994-...."}],"tag":200},{"ind2":" ","ind1":" ","subfield":[{"code":7,"content":"ba0yba0y"},{"code":"a","content":"Titulaire d'une thèse d'exercice en Pharmacie (Lyon 1, 2020)"}],"tag":340},{"ind2":3,"ind1":" ","subfield":[{"code":"a","content":"FR"},{"code":"b","content":"Abes"},{"code":"c","content":20210826},{"code":"g","content":"AFNOR"}],"tag":801},{"ind2":" ","ind1":" ","subfield":{"code":"a","content":"Les effets indésirables des anti-PD-1 (Nivolumab et Pembrolizumab) entrainant un arrêt temporaire ou définitif de l'immunothérapie en vie réelle / Sarah Burgniard ; sous la direction de Florence Ranchon [thèse], 2020"},"tag":810},{"ind2":" ","ind1":" ","subfield":{"code":"a","content":"Burgniard, Sarah (1994-....)"},"tag":900}],"controlfield":[{"tag":"001","content":249219093},{"tag":"003","content":"http://www.idref.fr/249219093"},{"tag":"004","content":20200922},{"tag":"005","content":20210826062222},{"tag":"006","content":692669902},{"tag":"007","content":692669902},{"tag":"008","content":"Tp5"}]}}